Cara Therapeutics, Inc. - Special Call Transcript
Good morning, and welcome to Cara Therapeutics KALM-2 top line data conference call. (Operator Instructions) Please be advised, the call is being recorded at Cara's request.
I would now like to turn the call over to the Cara team. Please proceed.
Good morning. This is Jane Urheim with Stern Investor Relations, and welcome to Cara Therapeutics KALM-2 top line data conference call. The news release became available earlier this morning and can be found on our website at www.caratherapeutics.com. You may also listen to a live webcast and replay of today's call on the News and Investors section of the website.
Before we begin, let me remind you that statements made on today's call regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Examples of these forward-looking statements include statements concerning plans,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |